Bloomberg Markets The Close Romaine Bostick breaks down the day's top stories and trading action leading into the close.
Bloomberg Businessweek Insight and analysis of top stories from our award winning magazine "Bloomberg Businessweek". Listen
Bloomberg Businessweek Highlights from a week-long virtual event bringing Bloomberg Businessweek magazine to life. Carol Massar and Tim Stenovec host a look back at the best interviews, discussions and more.
MarketsDealsMerck-Backed Kelun-Biotech Picks Banks for Hong Kong IPO, Sources SayKelun Pharma unit working with Citic Securities, Goldman SachsToo early to make a decision on biotech unit’s offering sizeByPei Li+FollowFebruary 23, 2023, 10:19 AM UTCUpdated onFebruary 24, 2023, 2:11 AM UTCA biotech subsidiary of Sichuan Kelun Pharmaceutical Co. selected Citic Securities Co. and Goldman Sachs Group Inc. to work on its upcoming initial public offering in Hong Kong, according to people familiar with the matter.Kelun-Biotech plans to list as soon as in 2023, the people said, asking not to be identified as the information is private. It is too early in the process to determine the offering size, the people said.
